19th Jan 2015 08:58
LONDON (Alliance News) - Deltex Medical Group PLC said Monday that it has signed an exclusive agreement with NASDAQ listed CAS Medical Systems to distribute CAS's FORE-SIGHT cerebral oximeter monitors in the UK and Ireland.
The agreement is effective from the beginning of 2015. Initial stocks and sales team training are being delivered this week, Deltex said.
No financial details of the agreement were disclosed. The company noted that UK hospitals purchased around GBP200,000 of FORE-SIGHT products in 2014.
"Cerebral oximetry is a complementary technology to our haemodynamic monitoring products and we are delighted to be able to sell the FORE-SIGHT systems which, based on our market research and technical due diligence, we believe to be best in class," said Chief Executive Officer Ewan Phillips in a statement.
Shares in Deltex Medical are trading up 2.5% at 4.10 pence Monday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical